Chester County News and Community Website
WASHINGTON, D.C. — Federal regulators are moving to reduce the use of animal testing in drug development, issuing new guidance to help drugmakers adopt alternative methods that rely on human-based …
FDA Push to Replace Animal Testing Signals Major Shift Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has launched a new centralized system that will allow scientists, regulators, and the public to analyze safety reports for drugs, vaccines, …
FDA Launches Real-Time Safety Database for Drugs and Vaccines Read More
EXTON, PA — Frontage Laboratories, Inc. announced a major expansion of its early phase clinical research capabilities across the United States and China, positioning the company to meet surging demand …
Frontage Scales Global Phase I Reach as Patent Cliff Accelerates Drug Trials Read More
BERWYN, PA — Mural Health Technologies, Inc. has expanded its support platform for clinical trial participants by adding pre-funded meal delivery services, a move the company says will help reduce …
Mural Health Adds Meal Delivery to Ease Burden on Clinical Trial Participants Read More
HARRISBURG, PA — The American Lung Association in Pennsylvania has announced the launch of its 2026-2027 Research Awards and Grants cycle, reaffirming its commitment to accelerating scientific discoveries that address …
American Lung Association Opens 2026-2027 Research Grant Cycle to Advance Lung Health Read More
WASHINGTON, D.C. — In a landmark move to improve transparency and modernize regulatory processes, the U.S. Food and Drug Administration (FDA) has published more than 200 complete response letters (CRLs) …
FDA Publishes Over 200 Complete Response Letters to Increase Drug Approval Transparency Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has initiated an immediate review of clinical trials involving the international transfer of Americans’ living cells for genetic engineering and subsequent …
FDA Investigates Clinical Trials Sending U.S. DNA Overseas Read More
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled key clinical efficacy data for rigosertib, showcasing its potential as a treatment for squamous cell carcinoma (SCC) associated with recessive …
Traws Pharma Announces Promising Clinical Data for Rigosertib in Rare Cancer Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) presented significant clinical findings at the 2025 American Urological Association (AUA) Annual Meeting in Las Vegas. The data from two randomized controlled trials …
Teleflex Highlights UroLift™ System’s Clinical Advantages at 2025 AUA Meeting Read More
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) will hold a live webcast aimed at providing patients, caregivers, and families with updates on its clinical trials and future plans. The virtual …
Annovis Bio to Host Patient-Centered Webcast on Key Clinical Developments Read More